ABOUT HIGHCAPE
HighCape Capital is a growth equity fund that invests in commercial-stage life sciences companies. We apply decades of combined investment and operational experience to transform our portfolio companies into sustainable businesses with multiple exit alternatives.
OUR TEAM
HighCape is a growth equity fund with a unique, multidisciplinary team of savvy executives. With decades of business success, HighCape transforms outstanding medical technology companies into sustainable businesses.
OUR TEAM
HighCape is a growth equity fund with a unique, multidisciplinary team of savvy executives. With decades of business success, HighCape transforms outstanding medical technology companies into sustainable businesses.
PHILOSOPHY
We have elected to keep our portfolio size small so that we can dedicate the time and effort required to help our companies grow into sustainable businesses. This allows us to customize our investment strategy to address the unique needs of each company:
Set a Solid Foundation
HighCape believes a strong management team with a thoughtful commercial strategy is key to a successful business. We actively partner with existing leadership to guide and optimize their management approach, which may involve filling key roles and/or advising on operational activities.
ACTIVELY PARTNER
HighCape leverages its Partner’s experience to help management teams identify and address the fundamental challenges and critical decisions businesses may encounter during the crossover from product development and approval stage to commercialization. This may include considerations from maximizing operational talent to establishing a capital structure from which to build a major business.
POSITION FOR GROWTH
HighCape produces sustainable businesses with multiple exit alternatives that generate strong financial returns for our limited partners. We do this by applying our investment, time and growth trajectories to establish the viability and scalability of the company’s business model.
HIGHCAPE INVESTS IN LIFE SCIENCES COMPANIES THAT:
Are in the pre-commercialization or early-commercialization stage
HighCape invests in life sciences companies that:
- Delivers clinical and financial value to the healthcare system
- Presents minimal regulatory risk
- Has a clear path to commercialization
Can benefit from an active collaboration with our experienced team of Partners
CONTACT US
Could HighCape be the right partner for your growing business?
Contact us for more information.
452 5th Ave, 21st Floor
New York, NY 10018